Welcome to LookChem.com Sign In|Join Free

CAS

  • or

92693-02-2

Post Buying Request

92693-02-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

92693-02-2 Usage

Origin

A metabolic product of arachidonic acid.

Enzyme involvement

Derived from the action of the enzyme 15-lipoxygenase.

Category

Bioactive lipid mediator.

Involvement in processes

Inflammation, immune response, and vascular regulation.

Properties

Anti-inflammatory and vasodilatory.

Role

Regulation of blood pressure and kidney function.

Implication in diseases

Hypertension, atherosclerosis, and cancer.

Current status

Ongoing research for biological functions and potential therapeutic applications.

Check Digit Verification of cas no

The CAS Registry Mumber 92693-02-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,2,6,9 and 3 respectively; the second part has 2 digits, 0 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 92693-02:
(7*9)+(6*2)+(5*6)+(4*9)+(3*3)+(2*0)+(1*2)=152
152 % 10 = 2
So 92693-02-2 is a valid CAS Registry Number.

92693-02-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 13, 2017

Revision Date: Aug 13, 2017

1.Identification

1.1 GHS Product identifier

Product name (15S)-15-hydroxyicosa-8,11,13-trienoic acid

1.2 Other means of identification

Product number -
Other names L-15-Hydroxy-8cis,11cis,13trans-eicosatriencarbonsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:92693-02-2 SDS

92693-02-2Downstream Products

92693-02-2Relevant articles and documents

PHARMACEUTICALLY ACCEPTABLE SALTS OF POLYUNSATURATED HYDROXY FATTY ACIDS

-

Paragraph 00144-00147, (2015/06/03)

The present disclosure provides pharmaceutically acceptable stable salt forms of 15-lipoxygenase products, such as 15-HETrE lysine salt, compositions comprising same and methods of making and using same.

Structural requirements for the inhibition of 5-lipoxygenase by 15-hydroxyeicosa-5,8,11,13-tetraenoic acid analogues

Haviv,Ratajczyk,DeNet,Martin,Dyer,Carter

, p. 254 - 263 (2007/10/02)

-

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 92693-02-2